NSETrading Window23 Jun 2026 · 23 Jun 2026, 05:09 pm

Trading Window

Entero Healthcare Solutions Limited · ENTERO

✦ AI Summary

Entero Healthcare Solutions Limited has announced the closure of its trading window for Designated Persons and their immediate relatives, effective July 01, 2026. This is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The date for the Board Meeting to consider these results will be intimated subsequently.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

ENTERO_23062026170844_Trading_Window_Closure.pdf

pdf

Download →
View document text
Ref: 15/SE/LC/2026-27 Date: June 23, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Intimation of Closure of Trading Window This is to inform you that pursuant to the Company’s Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for dealing in securities of the Company by the Designated Persons of the Company and their immediate relatives will be closed with effect from July 01, 2026 and shall remain closed up to 48 (Forty Eight) hours after declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. The date of the Board Meeting to consider the aforesaid Unaudited Financial Results of the Company will be intimated in due course of time. This is for your information and records. Yours Faithfully For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- General Counsel, Company Secretary & Compliance Officer